The first Astrazeneca plc trade was made in Q2 2013.
Since then Ken Griffin bought shares 64 more times and sold shares on 62 occasions. The investor completely sold their stake between Q1 2026 and Q1 2026.
Avg closing price
Price range
Sold -840k shares
Q1 2026
Avg closing price
$144.14
Price range
$89.94
-
$209.09
Sold 76.6% shares (-2.75M shares)
Q4 2025
Avg closing price
$87.78
Price range
$81.15
-
$93.32
Increased shares by 95.9% (+1.76M shares)
Q3 2025
Avg closing price
$75.65
Price range
$68.72
-
$82.11
Sold 10.5% shares (-215k shares)
Q2 2025
Avg closing price
$70.05
Price range
$64.87
-
$75.00
Sold 51.5% shares (-2.18M shares)
Q1 2025
Avg closing price
$72.18
Price range
$65.37
-
$77.96
Increased shares by 841.6% (+3.77M shares)
Q4 2024
Avg closing price
$69.86
Price range
$63.20
-
$79.58
Sold 27.4% shares (-169k shares)
Q3 2024
Avg closing price
$80.76
Price range
$76.67
-
$87.62
Increased shares by 26.4% (+129k shares)
Q2 2024
Avg closing price
$75.24
Price range
$66.81
-
$80.83
Increased shares by 13.9% (+59.7k shares)
Q1 2024
Avg closing price
$66.21
Price range
$61.03
-
$69.57
Sold 44.5% shares (-345k shares)
Q4 2023
Avg closing price
$65.00
Price range
$61.89
-
$69.28
Increased shares by 22.6% (+142k shares)
Q3 2023
Avg closing price
$68.29
Price range
$64.85
-
$71.70
Increased shares by 79.9% (+280k shares)
Q2 2023
Avg closing price
$73.57
Price range
$69.91
-
$75.81
Increased shares by 11.4% (+35.8k shares)
Q1 2023
Avg closing price
$67.27
Price range
$63.15
-
$71.60
Sold 80.8% shares (-1.33M shares)
Q4 2022
Avg closing price
$62.70
Price range
$54.21
-
$70.44
Increased shares by 12344.3% (+1.63M shares)
Q3 2022